What is the recommended dose of vitamin K (Vit K) to reverse warfarin (coumarin) anticoagulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin K Dosing for Warfarin Reversal

The recommended dose of vitamin K to reverse warfarin anticoagulation depends on the INR level and clinical scenario, ranging from 1-2.5 mg orally for mildly elevated INR (5-9) without bleeding to 5-10 mg intravenously for serious bleeding. 1, 2

Dosing Based on Clinical Scenario

Non-Bleeding Patient with Elevated INR

  • For INR between 5.0 and 9.0 without bleeding:

    • Withhold warfarin and administer 1.0-2.5 mg of vitamin K orally 3, 1
    • This typically lowers INR within 24-48 hours 3
    • For patients at higher risk of bleeding, consider oral vitamin K even for INR values between 4.5-5.0 3, 1
  • For INR >10 without bleeding:

    • Administer 3-5 mg oral vitamin K 1, 4
    • A study of 107 patients with INR >10 found that 2.5 mg oral vitamin K resulted in low rates of major bleeding (3.7% at 90 days) 4

Bleeding Patient

  • For non-life-threatening bleeding:

    • Administer 2-4 mg vitamin K orally for rapid reversal 3
    • If INR remains high after 24 hours, give additional 1-2 mg orally 3
  • For serious bleeding:

    • Administer 5-10 mg vitamin K by slow intravenous infusion (over 30 minutes) 1, 2
    • Intravenous administration produces a more rapid response but carries risk of anaphylactic reactions 3
  • For life-threatening bleeding:

    • Administer 10 mg intravenous vitamin K plus 4-factor prothrombin complex concentrate (PCC) 2
    • PCC is preferred over fresh frozen plasma due to faster onset of action (5-15 minutes vs. hours) 3, 2

Route of Administration Considerations

  • Oral administration:

    • Preferred for non-urgent reversal due to safety and convenience 3, 5
    • Predictably effective but takes longer to work than IV administration 3
    • Studies show oral vitamin K lowers INR more effectively than simply withholding warfarin 6
  • Intravenous administration:

    • More rapid INR reduction compared to oral route (44% vs 14% achieving INR ≤2 within 12 hours) 7
    • Should be administered by slow infusion over 30 minutes to reduce risk of anaphylactic reactions 3, 2
    • Recommended for serious or life-threatening bleeding 2
  • Subcutaneous administration:

    • Not recommended due to unpredictable and sometimes delayed response 3, 5

Important Clinical Considerations

  • High doses of vitamin K (>10 mg) may lower INR more than necessary and lead to warfarin resistance for up to a week 3, 1

  • The dose of vitamin K, route of administration, and baseline INR all significantly influence the rate and extent of INR reversal 8

  • For INR values between 2-5 mg, intravenous vitamin K doses of 2 mg or greater produce similar INR reduction 8

  • When resuming warfarin after high-dose vitamin K administration, bridging with heparin may be necessary until the patient becomes responsive to warfarin again 1, 9

  • Patient-specific factors increasing bleeding risk (age >65, history of stroke/GI bleeding, renal insufficiency, anemia) should be considered when determining vitamin K dosing 1, 2

  • For emergency surgery or procedures, the target INR should be <1.5, which typically requires 5-10 mg IV vitamin K plus PCC 2

References

Guideline

Vitamin K and Warfarin Interaction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Warfarin Reversal in Significant Bleeding or Emergency Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The use of vitamin K in patients on anticoagulant therapy: a practical guide.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.